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Since the serependitous discovery of the cisplatin antiproliferative activity, many
efforts have focused on the design of potent metal-based drugs for oncology
therapies. A large number of these complexes have been evaluated in vitro and in
vivo and some have reached clinical trials. However, while metallodrug chemistry
has developed to an advanced level, these emerging therapeutics have
encountered new hurdles including poor water solubility and pharmacological
deficiencies. Today, solutions to overcome these issues do not lie in synthesizing
new anticancer drugs but in finding suitable drug delivery strategies. Over the
past decades, various delivery systems have been developed including prodrug,
ligand design and nanocarriers aimed at enhancing the performance profile of
these novel metallodrugs.
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